BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9835510)

  • 1. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source.
    Bayer AS; Cheng D; Yeaman MR; Corey GR; McClelland RS; Harrel LJ; Fowler VG
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3169-72. PubMed ID: 9835510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source.
    Fowler VG; McIntyre LM; Yeaman MR; Peterson GE; Barth Reller L; Corey GR; Wray D; Bayer AS
    J Infect Dis; 2000 Oct; 182(4):1251-4. PubMed ID: 10979928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.
    Wu T; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 1994 Apr; 38(4):729-32. PubMed ID: 8031037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity.
    Bayer AS; Prasad R; Chandra J; Koul A; Smriti M; Varma A; Skurray RA; Firth N; Brown MH; Koo SP; Yeaman MR
    Infect Immun; 2000 Jun; 68(6):3548-53. PubMed ID: 10816510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.
    Mercier RC; Rybak MJ; Bayer AS; Yeaman MR
    Infect Immun; 2000 Aug; 68(8):4699-705. PubMed ID: 10899875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro.
    Yeaman MR; Sullam PM; Dazin PF; Bayer AS
    Infect Immun; 1994 Aug; 62(8):3416-23. PubMed ID: 8039912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
    Fowler VG; Sakoulas G; McIntyre LM; Meka VG; Arbeit RD; Cabell CH; Stryjewski ME; Eliopoulos GM; Reller LB; Corey GR; Jones T; Lucindo N; Yeaman MR; Bayer AS
    J Infect Dis; 2004 Sep; 190(6):1140-9. PubMed ID: 15319865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses.
    Kupferwasser LI; Yeaman MR; Shapiro SM; Nast CC; Bayer AS
    Circulation; 2002 Feb; 105(6):746-52. PubMed ID: 11839632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro.
    Yeaman MR; Norman DC; Bayer AS
    Infect Immun; 1992 Jun; 60(6):2368-74. PubMed ID: 1587603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.
    Yeaman MR; Bayer AS; Koo SP; Foss W; Sullam PM
    J Clin Invest; 1998 Jan; 101(1):178-87. PubMed ID: 9421480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Yeaman MR; Bayer AS
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftaroline activity against Staphylococcus aureus isolated from patients with infective endocarditis, worldwide (2010-2019).
    Sader HS; Carvalhaes CG; Mendes RE
    Int J Infect Dis; 2021 Jan; 102():524-528. PubMed ID: 33207274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
    Chua T; Moore CL; Perri MB; Donabedian SM; Masch W; Vager D; Davis SL; Lulek K; Zimnicki B; Zervos MJ
    J Clin Microbiol; 2008 Jul; 46(7):2345-52. PubMed ID: 18508934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus.
    Kupferwasser LI; Skurray RA; Brown MH; Firth N; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2395-9. PubMed ID: 10508013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis.
    Dankert J; Krijgsveld J; van Der Werff J; Joldersma W; Zaat SA
    J Infect Dis; 2001 Sep; 184(5):597-605. PubMed ID: 11494165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus infective endocarditis versus bacteremia strains: Subtle genetic differences at stake.
    Bouchiat C; Moreau K; Devillard S; Rasigade JP; Mosnier A; Geissmann T; Bes M; Tristan A; Lina G; Laurent F; Piroth L; Aissa N; Duval X; Le Moing V; Vandenesch F;
    Infect Genet Evol; 2015 Dec; 36():524-530. PubMed ID: 26318542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins.
    Bayer AS; Ramos MD; Menzies BE; Yeaman MR; Shen AJ; Cheung AL
    Infect Immun; 1997 Nov; 65(11):4652-60. PubMed ID: 9353046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011-2014).
    Mendes RE; Sader HS; Smart JI; Castanheira M; Flamm RK
    Eur J Clin Microbiol Infect Dis; 2017 Jun; 36(6):1013-1017. PubMed ID: 28111724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus.
    Dhawan VK; Yeaman MR; Cheung AL; Kim E; Sullam PM; Bayer AS
    Infect Immun; 1997 Aug; 65(8):3293-9. PubMed ID: 9234789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
    Lalani T; Federspiel JJ; Boucher HW; Rude TH; Bae IG; Rybak MJ; Tonthat GT; Corey GR; Stryjewski ME; Sakoulas G; Chu VH; Alder J; Steenbergen JN; Luperchio SA; Campion M; Woods CW; Fowler VG
    J Clin Microbiol; 2008 Sep; 46(9):2890-6. PubMed ID: 18596141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.